SCHEMBL14059477

SCHEMBL14059477

COc1ccccc1-c1ccc2c(NCCC3CC3)c(C#N)nnc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LRRK2 Q5S007 6/20 0.46
▸ PGR P06401 1/20 0.40
▸ AR P10275 1/20 0.40
▸ DHFR P00374 1/20 0.40
▸ ALDH1A1 P00352 8/20 0.39
▸ HSD17B10 Q99714 8/20 0.39
▸ CYP1A2 P05177 7/20 0.39
▸ CYP3A4 P08684 7/20 0.39
▸ CYP2D6 P10635 7/20 0.39
▸ TSHR P16473 7/20 0.39
▸ CLK4 Q9HAZ1 7/20 0.39
▸ CYP2C19 P33261 6/20 0.39
▸ LMNA P02545 5/20 0.39
▸ USP2 O75604 5/20 0.38
▸ CYP2C9 P11712 3/20 0.37
▸ MAPK1 P28482 3/20 0.37
▸ HIF1A Q16665 3/20 0.37
▸ KDM4E B2RXH2 3/20 0.37
▸ HPGD P15428 3/20 0.37
▸ GAA P10253 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14059572 0.89 LRRK2 (0.49) LRRK2
SCHEMBL14059793 0.89 LRRK2 (0.48) LRRK2
SCHEMBL14059413 0.88 LRRK2 (0.46) LRRK2
SCHEMBL14059154 0.88 LRRK2 (0.49) LRRK2ALDH1A1HSD17B10CYP1A2CYP3A4
SCHEMBL14059532 0.86 LRRK2 (0.44) LRRK2ARALDH1A1CYP1A2CYP3A4
SCHEMBL14059347 0.86 LRRK2 (0.52) LRRK2
SCHEMBL14059769 0.85 LRRK2 (0.46) LRRK2
SCHEMBL14059700 0.84 LRRK2 (0.49) LRRK2
SCHEMBL14062308 0.84 LRRK2 (0.55) LRRK2
SCHEMBL14059211 0.83 LRRK2 (0.52) LRRK2ALDH1A1HSD17B10USP2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2726465-A1 INHIBITORS OF LRRK2 KINASE ACTIVITY Elan Pharmaceuticals Inc. (US) 2014-05-07 — — EP claimed
WO-2012162254-A1 INHIBITORS OF LRRK2 KINASE ACTIVITY ELAN PHARMACEUTICALS, INC. (US) 2012-11-29 — — WO claimed
EP-2726465-A1 INHIBITORS OF LRRK2 KINASE ACTIVITY Elan Pharmaceuticals Inc. (US) 2014-05-07 — — EP disclosed
WO-2012162254-A1 INHIBITORS OF LRRK2 KINASE ACTIVITY ELAN PHARMACEUTICALS, INC. (US) 2012-11-29 — — WO disclosed
Send feedback